Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin (Q43931023)

28 November 2017

title

Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin (English)

1 reference

28 November 2017

Glendon R Tait

1

1 reference

28 November 2017

Karen McManus

2

1 reference

28 November 2017

François Bellavance

3

1 reference

28 November 2017

Nathalie Lara

4

1 reference

28 November 2017

Wendy Chrapko

5

1 reference

28 November 2017

Jean-Michel Le Mellédo

6

1 reference

28 November 2017

publication date

1 May 2002

1 reference

28 November 2017

published in

Psychoneuroendocrinology

1 reference

28 November 2017

volume

27

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

417-429

1 reference

Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Premenstrual exacerbation of symptoms in women with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Comorbid psychiatric disorders in subjects with panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

GABAergic agents and panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Effects of antidepressant treatment on neuroactive steroids in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Neuroactive steroid levels in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

A case of panic disorder induced by oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

The cross-national epidemiology of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900051-8

7 January 2021

10.1016/S0306-4530(01)00051-8

Identifiers

DOI

1 reference

28 November 2017

1 reference